Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.95USD
20 Apr 2018
Change (% chg)

$-0.05 (-2.50%)
Prev Close
$2.00
Open
$1.98
Day's High
$2.01
Day's Low
$1.91
Volume
6,785
Avg. Vol
37,649
52-wk High
$21.86
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 -0.006
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 10.00 10.00 10.00 --
Year Ending Dec-18 3 3.33 10.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 2 -0.42 -0.30 -0.54 --
Quarter Ending Sep-18 2 -0.47 -0.26 -0.68 --
Year Ending Dec-18 2 -1.80 -0.90 -2.71 -5.68
Year Ending Dec-19 2 -2.12 -0.83 -3.42 -4.05
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta -7.16 0.75 0.80
Price to Sales (TTM) -- 136.15 7.07
Price to Book (MRQ) 1.49 19.54 5.13
Price to Tangible Book (MRQ) 1.49 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions 24.57 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -- 79.72 10.83
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.23 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago -69.76 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate -- 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 3.19 5.97 3.62
LT Debt to Equity (MRQ) -- 23.32 11.31
Total Debt to Equity (MRQ) -- 25.75 13.97
Interest Coverage (TTM) -- -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.18 15.89
Operating Margin (TTM) -- -563.03 4.33
Operating Margin - 5 Yr. Avg. -- -164.18 11.25
Pre-Tax Margin (TTM) -- -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -171.12 11.56
Net Profit Margin (TTM) -- -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -- -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,887,722 816,988,634
Net Income/Employee (TTM) -- 956,935 96,050,323
Receivable Turnover (TTM) -- 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -86.95 -0.77 10.54
Return on Assets - 5 Yr. Avg. -71.51 0.70 11.56
Return on Investment (TTM) -120.23 -0.74 13.19
Return on Investment - 5 Yr. Avg. -101.20 4.20 14.97
Return on Equity (TTM) -120.46 -2.80 15.00
Return on Equity - 5 Yr. Avg. -102.45 -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -69.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.57%
# of Holders: 20
Total Shares Held: 3,748,803
3 Mo. Net Change: -400
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.